Coloplast AS Class B COLO B

Morningstar Rating
DKK 412.50 −2.80 (0.67%)
View Full Chart

Company Report

Price vs Fair Value

COLO B is trading at a LOCK|#<<yHCJ premium.
Price
DKK 415.30
Fair Value
bM!
Uncertainty
LOCK|^S%r?
1-Star Price
C?Z
5-Star Price
?z^
Economic Moat
LOCK|cxV>
Capital Allocation
LOCK|P%x@Jf

Bulls Say, Bears Say

Bulls

Coloplast's dominant position in ostomy and continence care is built on decades of innovation and customer relationships that are difficult to replicate and supports both pricing resilience and long-term customer retention.

Bears

With the majority of revenue subject to third-party reimbursement, Coloplast is structurally exposed to healthcare cost containment—most concretely illustrated by the anticipated introduction of Medicare competitive bidding in the US from 2028 onward.

Trading Information

Previous Close Price
DKK 415.30
Day Range
DKK 410.60–415.30
52-Week Range
DKK 369.70–631.40
Bid/Ask
DKK 412.40 / DKK 412.90
Shares Outstanding
225.37M
Market Cap
DKK 92.96B
Volume/Avg
357,279 / 330,201

Key Statistics

Price/Earnings (Normalized)
31.97
Price/Sales
3.29
Dividend Yield (Trailing)
5.54%
Dividend Yield (Forward)
5.54%
Dividend Payment Schedule
May, Dec
Total Yield
5.54%

Company Profile

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
17,213

Competitors

Valuation

Metric
COLO B
CTEC
SNN
Price/Earnings (Normalized)
31.9722.3213.73
Price/Book Value
7.003.932.17
Price/Sales
3.292.321.82
Price/Cash Flow
11.9512.549.34
Price/Earnings
COLO B
CTEC
SNN

Financial Strength

Metric
COLO B
CTEC
SNN
Quick Ratio
0.881.061.11
Current Ratio
1.561.932.14
Interest Coverage
6.653.345.42
Quick Ratio
COLO B
CTEC
SNN

Profitability

Metric
COLO B
CTEC
SNN
Return on Assets (Normalized)
11.86%9.54%8.51%
Return on Equity (Normalized)
38.99%22.72%17.09%
Return on Invested Capital (Normalized)
15.76%13.15%11.66%
Return on Assets
COLO B
CTEC
SNN

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|Sr^^c>@LOCK|J#<$142B
Becton Dickinson & Co
BDX
LOCK|zVLOCK|rW%p$49B
ResMed Inc
RMD
LOCK|N!%phB&LOCK|wJqJ$31B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|?m@>h@>LOCK|@?Dz$31B
Alcon Inc
ALC
LOCK|!v<#bS%LOCK|^yNW?$31B
West Pharmaceutical Services Inc
WST
LOCK|%<y@>%#LOCK|?$$26B
Solventum Corp
SOLV
LOCK|Flp<#BQLOCK|nHw$15B
Baxter International Inc
BAX
LOCK|@#LOCK|&#Bw%$12B
The Cooper Companies Inc
COO
LOCK|ZQ$!JrcLOCK|^&TJ$11B
Align Technology Inc
ALGN
LOCK|X?##hKcLOCK|Tvz>$10B

Sponsor Center